How advances in heart imaging can help improve diagnoses
Watch this video and learn about Adler Imaging and the Cyclotron
A cyclotron is an apparatus in which charged atomic and subatomic particles are accelerated by an alternating electric field while following an outward spiral or circular path in a magnetic field.
When cardiologists refer patients to Adler Imaging, the focus is on getting accurate results by diagnosing even the most complicated heart damage faster and with more accuracy than ever before.
Why Cardiologists are Referring Patients for a PET/CT Myocardial Perfusion Imaging with N-13 Ammonia:
-PET/CT MPI imaging provides the most accurate images of blood flow in the heart
-PET/CT MPI imaging is the best way to assess CAD and direct management of heart disease
-PET/CT MPl is considered the 'gold standard' in enabling a cardiologist to determine the extent of permanent damage to heart tissue
All Maior Insurance Plans are Accepted
At Adler Imaging, we understand that health insurance protects your patients from unexpected, high medical costs. This is why we are committed to accepting all major health insurance plans. We are here to ease the stress when patients are referred to us and focus on comfort, dignity and results.
N-13 Ammonia: The Significant Advantages
There are significant advantages to this non-invasive cardiology imaging utilizing N-13 Ammonia and, specifically, should be performed on patients with:
Obesity (BMI greater than 30)
Protuberant abdomen and chest wall deformities
Requiring pharmacologic stress
Large breasts or implants
Requiring myocardial blood flow assessment
Faster Results with the Utmost Accuracy
Cardiac PET/CT MPI imaging combined with the ability to quantitatively measure myocardial blood flow is creating a paradigm shift in the speed and accuracy of the evaluation and management of patients with CAD.
Easy Access for all Patients
100% COVID-10 compliant
Easy parking and direct access
No steps
No elevators
Not a hospital
Individual waiting rooms - TVs and climate control
Cardiac PET
Cardiac PET Myocardial Perfusion Imaging (MPI) is a Medicare approved first line test for non-invasive cardiology evaluation that is projected to grow over 60% in the next 5 years. Cardiac PET is rapidly being adopted and it’s not a matter of if cardiac PET is coming, it is a matter of when. It is a powerful, non-invasive imaging tool available now that can assess myocardial blood flow (MBF) of the entire coronary circulation and has been demonstrated to be useful in the assessment of microvascular and triple vessel disease. Microvascular disease is known to be highly prevalent in women, as well as patients with cardiometabolic risk factors.
Reimbursement
Reimbursement is critical to the financial viability of any Cardiac PET program. N-13 Ammonia is FDA-approved and reimbursed by Medicare and most private payers. Plus, Adler Imaging stands ready to help you navigate the reimbursement process so you can focus on what you do best: delivering the best care possible.
Full Prescribing Information
INDICATIONS AND USAGE
N-13 Ammonia Injection is a radioactive diagnostic agent for Positron Emission Tomography (PET) indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.
CONTRAINDICATIONS
None known.
ADVERSE REACTIONS
No adverse reactions have been reported for N-13 Ammonia Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system.
WARNINGS AND PRECAUTIONS
N-13 Ammonia Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker.
Peer-reviewed Journals and Whitepapers